Condition
Pancreatic Ductal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Pancreatic Ductal Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in Canada (1), China (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using Patient-Derived Tumor Organoids to Choose a Drug for Pancreatic Cancer
This study tests whether selecting a drug based on a patient’s tumor organoids helps people with advanced pancreatic cancer respond to treatment.
-
Testing JAB-21822 and JAB-3312 in patients with advanced solid tumors and KRAS p.G12C mutation
This study is testing a new combination of drugs, JAB-21822 and JAB-3312, to see if it helps people with advanced solid tumors that have a specific KRAS mutation.
Related topics
Quick answers
How many Pancreatic Ductal Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.